Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01495650
Other study ID # APAD
Secondary ID 2010-A00906-33
Status Completed
Phase Phase 3
First received December 15, 2011
Last updated August 16, 2017
Start date December 2010
Est. completion date December 2014

Study information

Verified date August 2017
Source Institut du Cancer de Montpellier - Val d'Aurelle
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cancer-related fatigue is by far the most common symptom affecting cancer patients. Combining regular dietary counseling and tailored physical activity is associated with reduced cancer-related fatigue and can improve quality of life and body weight control. We propose to conduct a randomized controlled trial which purpose is to evaluate the effect of an intervention combining physical exercise and nutritional therapeutic education on cancer-related fatigue. To gain behavioral change towards PA and nutrition habits, interventions will take place within hospitals, on the same days of adjuvant treatments.


Description:

Cancer-related fatigue is by far the most common symptom affecting cancer patients. Combining regular dietary counseling and tailored physical activity is associated with reduced cancer-related fatigue and can improve quality of life and body weight control. We propose to conduct a randomized controlled trial which purpose is to evaluate the effect of an intervention combining physical exercise and nutritional therapeutic education on cancer-related fatigue. To gain behavioral change towards PA and nutrition habits, interventions will take place within hospitals, on the same days of adjuvant treatments.


Recruitment information / eligibility

Status Completed
Enrollment 240
Est. completion date December 2014
Est. primary completion date June 2014
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 76 Years
Eligibility Inclusion Criteria:

- Female patient with histologically proven breast cancer

- 18-76 years old

- Patients having undergone curative surgery and eligible to 6 cycles of adjuvant chemotherapy (6 FEC100, or 3FEC100 + taxanes) followed by radiotherapy

- Satisfactory healing of breast and lymph nodes area

- Ability to understand the nature, goal and study methodology

- Consent to cooperate for clinical assessments

- Affiliation to a social security regime or beneficiary of equivalent social protection

- Written informed consent provided before any study specific procedures

Exclusion Criteria:

- HER2 positive or metastatic cancer

- Any other primary tumor

- Contraindication to moderate physical activity

- Contraindication to adjuvant chemotherapy or radiotherapy

- Pregnancy or breast feeding

- Inability to attend or comply with interventions or follow-up scheduling, disability or difficulty preventing a proper understanding of trial

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Tailored program of PA and nutritional counseling
Patients receive tailored program of physical exercises and nutritional counseling during the course of adjuvant treatments (CT followed by RT, 27 weeks).

Locations

Country Name City State
France CRLC Val d'Aurelle-Paul Lamarque Montpellier

Sponsors (1)

Lead Sponsor Collaborator
Institut du Cancer de Montpellier - Val d'Aurelle

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Subjective fatigue Subjective fatigue is measured using the Multidimensional Fatigue Inventory (MFI-20) questionnaire At 18 months
Secondary Quality of life Quality of life is measured by the EORTC QLC-C30 questionnaire At 18 months
Secondary Anxiety/depressive symptoms Anxiety/depressive symptoms is measured by the HADS questionnaire At 18 months
Secondary Physical activity level Physical activity level is measured by the GPAQ questionnaire At 18 months
Secondary Muscular fatigue Muscular fatigue is measured by Myotest At 18 months
Secondary Attention fatigue Attention fatigue is measured usingt the TAP 2.2 software At 18 months
Secondary Body Mass Index Body Mass Index is calculated using bodyweight and length measurements At 18 months
Secondary Body composition Body composition (fat mass/fat-free mass ratio) is assessed by dual-energy X-ray absorptiometry (DEXA) At 18 months
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A